In vivo γδ T Cell Priming to Mycobacterial Antigens by Primary Mycobacterium tuberculosis Infection and Exposure to Nonpeptidic Ligands

Fabrizio Poccia, Miroslav Malkovsky, Aaron Pollak, Vittorio Colizzi, Guido Sireci, Alfredo Salerno, Francesco Dieli
1999 Molecular Medicine  
The recognition of phosphorylated nonpeptidic microbial metabolites by Vy9V62 T cells does not appear to require the presence of MHC molecules or antigen processing, pennitting rapid responses against microbial pathogens. These may constitute an imnportant area of natural anti-infectious immunity. To provide evidence of their involvement in immune reactivities against mycobacteria, we measured the responsiveness of peripheral blood Vy9V62 T cells in children with primary Mycobacterium
more » ... is (MTB) infections. Materials and Methods: Peripheral blood mononudear cells from 22 children with MTB infections and 16 positivity of tuberculin (PPD)-negative healthy children were exposed to nonpeptidic antigens in vitro and the reactivity of the Vy9V62 T cell subset with these antigens was determined using proliferation and cytokine assays. Also, responses of yS T cells from rhesus monkeys stimulated with phosphoantigens in vivo were measured. Results: The Vy9Va2 T cell responses were highly increased in infected children in comparison with agematched controls. This augmented Vy9V62 T cell reactivity subsided after successful antibiotic chemotherapy, suggesting that persistent exposure to mycobacterial antigens is required for the maintenance of 'y6 T cell activation in vivo. The in vivo reactivity of Vy9VS2 T cells to phosphoantigens was also analyzed in a rhesus monkey model system. Intravenous injections of phosphoantigens induced an activated state of simian Vy9V82 T cells which decreased after 2 months, i.e., with a time course similar to that seen in MTB-infected children. Conclusions: The increased reactivity of Vy9V62 T cells to phosphoantigens appears to be dependent on constant antigenic exposure. Consequently, the assessment of Vy9VS2 responses may be useful for monitoring the efficacy of antimycobacterial therapies.
doi:10.1007/bf03403540 fatcat:3eypw2zp5bbppeoooj3c3drmfa